Back to results
RecruitingPhase 2

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

NCT06178159

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

Contact

Jianmin Fang, Ph.D

+8610-58075763Jianminfang@hotmail.com
View on ClinicalTrials.gov
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer — TrialFind